Regenxbio RGNX
NASDAQ RGNX
$7.43 +0.01 (+0.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenxbio (RGNX) EPS (Diluted) (2016 - 2026)

Updated

Regenxbio (RGNX) reported EPS (Diluted) of $0.43 for Q2 2026, compared with -$1.38 a year earlier.

Analysis

Regenxbio (RGNX) EPS (Diluted) (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Regenxbio's EPS (Diluted) came in at -$3.34; for FY2025, it was -$3.76.

  • By year, EPS (Diluted) came in at -$4.59 in FY2024, -$6.02 in FY2023, -$6.50 in FY2022 and $2.91 in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly EPS (Diluted) since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 7.94
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.27
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 2.04
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -0.54
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 1.67
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.85
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 4.37
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -8.44
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -0.04
10 Regenxbio 401.90 Mn -531.19 Mn - 0.43
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.43
Dec 31, 2025 -1.30
Sep 30, 2025 -1.20
Jun 30, 2025 -1.38
Mar 31, 2025 0.12
Dec 31, 2024 -1.03
Sep 30, 2024 -1.17
Jun 30, 2024 -1.05
Mar 31, 2024 -1.38
Dec 31, 2023 -1.44
Sep 30, 2023 -1.41
Jun 30, 2023 -1.66
Mar 31, 2023 -1.53
Dec 31, 2022 -1.39
Sep 30, 2022 -1.75
Jun 30, 2022 -1.58
Mar 31, 2022 -1.79
Dec 31, 2021 6.70
Sep 30, 2021 -1.37
Jun 30, 2021 -1.36
API Access

Regenxbio EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=RGNX&period=max&api_key=YOUR_API_KEY